Safety and Immunogenicity of Hexavalent Vaccine(DTwP-HepB-IPV-Hib) in Healthy Infants

PHASE2UnknownINTERVENTIONAL

Enrollment

336

Participants

Timeline

Start Date

November 30, 2019

Primary Completion Date

April 30, 2020

Study Completion Date

August 31, 2020

Conditions

DiphtheriaTetanusPertussisHepatitis BPoliomyelitisHaemophilus Influenzae Type b Infection

Interventions

BIOLOGICAL

DTwP-HepB-Sabin IPV-Hib

Intramuscular injection into the anterolateral area of the thigh

BIOLOGICAL

Pentavalent vaccine and Salk IPV

Intramuscular injection into anterolateral area of the thigh